Interview with Kitima Yuthavong, CEO, PREMA Thailand
PReMa was established in 2004 after a period of transformation to represent the growing role of its members, research-based companies. To begin with, could you explain us the main milestones…
Address: 408/85, 19th Floor, Phaholyothin Place Bldg. Phaholyothin Road Samsennai, Phayathai Bangkok 10400,Thailand
Tel: (02) 619-0232
PREMA is a non-profit organization representing members who are research based pharmaceutical companies innovating medicines to combat the previously incurable diseases and to improve on existing treatments.
The Pharmaceutical Research and Manufacturers Association (PReMA) is dedicated to promoting good health and quality of life for the Thai people and to support the advancement of public health systems through the research and development of innovative medicines. PReMA also supports the rights to choice by the people and the healthcare professionals to high quality medicines that best meet their needs.
PReMa was established in 2004 after a period of transformation to represent the growing role of its members, research-based companies. To begin with, could you explain us the main milestones…
Dr Tares Krassanairawiwong, secretary-general of the Thai FDA shares the recent reforms carried out in the hope of facilitating greater patient access to both domestic and internationally-produced treatments. Dr Krassanairawiwong…
Sumalee Kristarnin, country president of Novartis Thailand, shares the main initiatives of the affiliate in Thailand to take care of people, employees and patients. She highlights how the key priorities,…
Dr Somvong Tragoonrung, executive director of BIOTEC, one of the first biotechnology-focused research institutes in Thailand, highlights their current research in biotechnology and genomics projects, as well as the local…
Nares Damrongchai and Sirasak Teparkum from the Thailand Center of Excellence for Life Sciences (TCELS) lay out current challenges in the Thai healthcare and life sciences industry, their mains axes…
Dr Ekaphop Sirachainan, president of the Thai Society of Clinical Oncology, explains the need to increase patient access to oncology treatment in Thailand, and the crucial need for collaboration with…
Peter Streibl, general manager of Takeda Thailand, highlights the importance of emerging markets for Takeda globally, as well as the 50–year long commitment of Takeda to Thailand and Thai patients.…
Thanakorn and Lakana Ounpiyodom of AeroCare highlight their unique positioning in the inhaler niche and how they have grown both their portfolio and facilities through strategic M&A. They share their…
Prof. Dr. Prasit Palittapongarnpim, Executive Vice President of Research and Development Management and International Collaboration at the Thai National Science Technology Development Agency (NSTDA), explains the main challenges and priorities…
Dr Roland Wein, Executive Director of the German-Thai Chamber of Commerce, explains the evolution of the business relationship between Thailand and Germany, discusses the chamber’s role in facilitating business opportunities…
Thailand has experienced a steady decline in infectious disease rates in the last generation thanks to the country’s commitment to life sciences research. The executive vice president of the National…
Dr Wannee Nitiyanant, president of the Diabetes Association of Thailand and Dr Supawadee Likitmaskul, president of the Siriraj Diabetes Center of Excellence, highlight the crucial importance of educate the public,…
Thailand has recently gained a new status as the first Asian country to legalise medical cannabis for medical treatment and research. In a sweeping move, the Thai parliament voted unanimously…
See our Cookie Privacy Policy Here